Bravenboer, Bert

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis

The MAGIC investigators, Voight, B. F., The GIANT Consortium, Scott, L. J., Steinthorsdottir, V., Morris, A. P., Dina, C., Welch, R. P., Zeggini, E., Huth, C., et al. (2010) · Nature Genetics

Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and Animals

Cited by 1,761

A Systematic Review and Meta-Analysis of Endocrine-Related Adverse Events Associated with Immune Checkpoint Inhibitors

de Filette, J., Andreescu, C., Cools, F., Bravenboer, B., & Velkeniers, B. (2019) · Hormone and Metabolic Research

Cancer Immunotherapy and BiomarkersAdrenal Hormones and Disorders

Cited by 381

Incidence of Thyroid-Related Adverse Events in Melanoma Patients Treated With Pembrolizumab

de Filette, J., Jansen, Y., Schreuer, M., Everaert, H., Velkeniers, B., Neyns, B., & Bravenboer, B. (2016) · The Journal of Clinical Endocrinology & Metabolism

Cancer Immunotherapy and BiomarkersThyroid Disorders and Treatments

Cited by 244

Pseudomalabsorption of levothyroxine: a challenge for the endocrinologist in the treatment of hypothyroidism

Van Wilder, N., Bravenboer, B., Herremans, S., Vanderbruggen, N., & Velkeniers, B. (2017) · European Thyroid Journal

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 31